Introduction
The paper compares the financial performance of Abcam and Novozymes for the FY 2015. The company (Abcam) spends a lot of cash on research and development. Therefore, it provides easy access to products, high development on the platform of e-commerce. The sales of Abcam increased significantly between FY 2015 and 2016. That is it almost made 90% of sales in other currencies such as the Japanese Yen, and Euro. The change in these foreign currencies during the recession period is favorable for the firm. Moreover, revenues of the product increased by over 15% on the reported basis during FY ...